CTM vs MAPS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is severely compromised, highlighted by a Piotroski F-Score of 1/9, indicating critical financial weakness. While the company maintains a strong liquidity position (Current Ratio 4.40) and positive revenue growth (21.9%), these are offset by consistent net losses and a total lack of earnings beats. Bearish technical trends and aggressive insider selling further signal a lack of confidence in the short-to-medium term outlook.
MAPS exhibits a stable but mediocre Piotroski F-Score of 4/9, which fails to offset a catastrophic technical and fundamental decline. While the company maintains impressive gross margins (94.94%) and a healthy current ratio (2.34), these are overshadowed by negative revenue growth (-9.70%) and a collapse in EPS growth (-250%). The stark disconnect between the analyst target price ($2.61) and the actual price action, combined with aggressive C-suite insider selling, suggests a lack of confidence in the company's turnaround potential.
Compare Another Pair
Related Comparisons
CTM vs MAPS: Head-to-Head Comparison
This page compares Castellum, Inc. (CTM) and WM Technology, Inc. (MAPS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.